Plain-English translation of NCT02863757 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is following patients who have chronic hepatitis B (a viral infection of the liver), nonalcoholic fatty liver disease (fat buildup in the liver), or both conditions together. Researchers want to understand how these diseases progress over time and what complications may develop, especially when both conditions exist in the same person.
When patients have both hepatitis B and fatty liver disease at the same time, doctors don't yet fully understand how these conditions interact or what the long-term risks are. This study aims to fill that gap so doctors can better predict and prevent serious complications like cirrhosis or liver cancer.
You likely qualify if…
You likely don't qualify if…
You would visit the research clinic periodically over at least 12 months for medical check-ups, blood tests, and imaging scans to monitor your liver health. Researchers will track whether your condition stays stable, improves, or worsens, and document any complications that develop. The study compares outcomes between people with hepatitis B alone, fatty liver alone, and those with both conditions.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China
Enrollment target
~1,500 participants
Started
August 2016
Primary completion
December 2026
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
George Lau, MD
Humanity and Health Research Centre
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.